Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells

Biochemical and Biophysical Research Communications

Volumn 370, Issue 3, 2008, Pages 489-494

  He, Yingbo ^a   Chang, Guodong ^b   Zhan, Shunli ^b   Song, Xiaomin ^a   Wang, Xiaofeng ^a   Luo, Yongzhang ^a  

^a Beijing Key Laboratory for Protein Therapeutics   (China)

^b Protgen Ltd   (China)

Author keywords

Angiogenesis; Endothelial cells; Internalization; Migration; Tissue factor; Tubule formation

Indexed keywords

THROMBOPLASTIN;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND HEALING;

ANGIOGENESIS INDUCING AGENTS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; STRESS FIBERS; THROMBOPLASTIN; WOUND HEALING;

EID: 43049132862     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.133     Document Type: Article

References (22)

1. Bach R.R. Initiation of coagulation by tissue factor. CRC Crit. Rev. Biochem. 23 (1988) 339-368
2. Belting M., Ahamed J., and Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1545-1550
3. Bogdanov V.Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., and Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat. Med. 9 (2003) 458-462
4. Yu J.L., May L., Lhotak V., Shahrzad S., Shirasawa S., Weitz J.I., Coomber B.L., Mackman N., and Rak J.W. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105 (2005) 1734-1741
5. Diamant M., Nieuwland R., Pablo R.F., Sturk A., Smit J.W., and Radder J.K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106 (2002) 2442-2447
6. Folkman J., Merler E., Abernathy C., and Williams G. Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133 (1971) 275-288
7. Ausprunk D.H., and Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14 (1977) 53-65
8. Bussolino F., Mantovani A., and Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22 (1997) 251-256
9. Magdolen V., Albrecht S., Kotzsch M., Haller C., Bürgle M., Jacob U., Grosser M., Kessler H., Graeff H., Müller M., Schmitt M., and Luther T. Immunological and functional analyses of the extracellular domain of human tissue factor. Biol. Chem. 379 (1998) 157-165
10. Shi H., Huang Y., Zhou H., Song X., Yuan S., Fu Y., and Luo Y. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 110 (2007) 2899-2906
11. He Y., Zhou H., Tang H., and Luo Y. Deficiency of disulfide bonds facilitating fibrillogenesis of endostatin. J. Biol. Chem. 281 (2006) 1048-1057
12. Huang Y., Shi H., Zhou H., Song X., Yuan S., and Luo Y. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107 (2006) 3564-3571
13. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
14. Lee M.S., Moon E.J., Lee S.W., Kim M.S., Kim K.W., and Kim Y.J. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res. 61 (2001) 3290-3293
15. Gotlieb A.I. The endothelial cytoskeleton: organization in normal and regenerating endothelium. Toxicol. Pathol. 18 (1990) 603-617
16. Hansen C.B., Pyke C., Petersen L.C., and Rao L.V. Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor. Blood 97 (2001) 1712-1720
17. Hamik A., Setiadi H., Bu G., McEver R.P., and Morrissey J.H. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. J. Biol. Chem. 274 (1999) 4962-4969
18. Gho Y.S., Kleinman H.K., and Sosne G. Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res. 59 (1999) 5128-5132
19. Koch A.E., Halloran M.M., Haskell C.J., Shah M.R., and Polverini P.J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376 (1995) 517-519
20. Giesen P.L., Rauch U., Bohrmann B., Kling D., Roqué M., Fallon J.T., Badimon J.J., Himber J., Riederer M.A., and Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc. Natl. Acad. Sci. USA 96 (1999) 2311-2315
21. Kakkar A.K., DeRuvo N., Chinswangwatanakul V., Tebbutt S., and Williamson R.C. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 346 (1995) 1004-1005
22. Higure A., Okamoto K., Hirata K., Todoroki H., Nagafuchi Y., Takeda S., Katoh H., Itoh H., Ohsato K., and Nakamura S. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis. Thromb. Haemost. 75 (1996) 791-795